Cyanotech Completes Going-Private Transaction, Initiates Delisting Process
summarizeSummary
Cyanotech Corporation has filed a final amendment confirming the completion of its reverse/forward stock split, effectively taking the company private and initiating the process to terminate SEC reporting obligations.
check_boxKey Events
-
Going-Private Transaction Completed
On February 9, 2026, Cyanotech completed its previously announced reverse/forward stock split, effectively taking the company private.
-
Minority Shareholders Cashed Out
Shareholders owning fewer than 400 pre-split shares were cashed out at $0.47 per share, extinguishing their equity interest.
-
Intent to Delist
The company now has fewer than 300 record holders and intends to file a Form 15 to terminate its SEC registration and reporting obligations.
-
Transaction Costs
The total cost for the transaction, including cash payments and related fees, is approximately $207,735.96, funded from existing cash.
auto_awesomeAnalysis
This SC 13E3/A Amendment No. 2 marks the definitive conclusion of Cyanotech's 'going private' transaction, which was previously disclosed on January 12, 2026, and further detailed on February 3, 2026. The company completed a 400-for-1 reverse stock split on February 9, 2026, followed by a 1-for-400 forward split. Shareholders holding fewer than 400 pre-split shares were cashed out at $0.47 per share. The primary objective was to reduce the number of record holders to below 300, enabling the company to terminate its SEC registration and reporting obligations by filing a Form 15. This event fundamentally alters the investment thesis for public shareholders, as their ownership has been extinguished, and the stock will no longer trade publicly.
At the time of this filing, CYAN was trading at $0.47 on OTC in the Life Sciences sector, with a market capitalization of approximately $3.4M. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.